Announcements A Joint Statement on Technical, legal, ethical and implementation concerns regarding Aarogya Setu and other apps introduced during COVID-19 in India by Jan Swasthya Abhiyan (JSA), Internet Freedom Foundation (IFF), Forum for Medical Ethics Society (FMES), and All India People’s Science Network (AIPSN)   |   Submission to the National Human Rights Commission (NHRC) on behalf of Hub5 (HEaL Institute, APU, Seher-CHSJ, and IAPH) – COPASAH on human rights issues confronted by ASHAS and ANMs during the Covid-19 pandemic | Aug 7, 2020   |   Letter to MMC by FMES, PUCL-MH, FAOW, and MFC urging to restore its order suspending licenses of two doctors accused of abetting the suicide of Dr Payal Tadvi

The SUPPORT controversy and learnings

Sunita V S Bandewar

DOI: 10.20529/IJME.2015.005


Over the past year, the Surfactant, Positive Pressure, and Oxygenation Randomized Trial (SUPPORT) has generated yet another rich debate relating to the study of treatments that fall within the standard of care. This was triggered by the investigational intervention – the compliance-oversight determination letter (2) – by the Office for Human Research Protections of the US Department of Human and Health Services. A large number of bioethicists, researchers, members of ethics review boards, neonatologists and parents of those receiving care have contributed to this discourse.

Full Text





There are currently no refbacks.

Article Views

PDF Downloads

Click here to support US